LUTONIX 035AV DRUG COATED BALLOON PTA CATHETER 9010 LX35100860V

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,other, report with the FDA on 2018-12-12 for LUTONIX 035AV DRUG COATED BALLOON PTA CATHETER 9010 LX35100860V manufactured by C.r. Bard, Inc. (gfo).

Event Text Entries

[130473819] Analysis/preliminary evaluation: upon receipt of the sample, visual examination of the entire length of the catheter revealed a longitudinal material rupture extending from the proximal balloon bond to the middle of the balloon. Functional testing of the complaint sample concluded the longitudinal material rupture would not allow the balloon to inflate. The complaint sample was decontaminated and prepared for further evaluation. A lot history review revealed this is the only complaint associated with this lot. A review of the device history record (dhr) indicates the lot was manufactured to specification. Conclusion: the returned sample is undergoing evaluation, which has not yet been completed. The dhr found nothing to indicate a manufacturing related cause for this event. Upon completion of the investigation, a supplement report will be submitted with all relevant information.
Patient Sequence No: 1, Text Type: N, H10


[130473820] It was reported a lutonix percutaneous transluminal drug coated balloon (dcb) dilatation catheter allegedly ruptured while treating a non calcified target lesion located in the av fistula. The health care professional (hcp) gained access from the patient's arm with a 7 french boston scientific super sheath over an 035 bentson guidewire. Reportedly, the hcp predilated the target lesion with a 8 x 60mm mustang percutaneous transluminal angioplasty (pta) balloon. The hcp reached the target lesion with the lutonix dcb and attempted to inflate the balloon. Reportedly, on the first inflation the lutonix dcb allegedly ruptured after achieving 8 atmospheres (atms) of pressure. The procedure was completed with an additional lutonix dcb. The lutonix dcb was returned for evaluation. No adverse patient outcomes were reported.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3006513822-2018-00285
MDR Report Key8156176
Report SourceCOMPANY REPRESENTATIVE,OTHER,
Date Received2018-12-12
Date of Report2019-01-10
Date of Event2018-11-15
Date Mfgr Received2019-01-08
Device Manufacturer Date2018-04-27
Date Added to Maude2018-12-12
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMIKE GAFFNEY
Manufacturer Street9409 SCIENCE CENTER DR
Manufacturer CityNEW HOPE MN 55428
Manufacturer CountryUS
Manufacturer Postal55428
Manufacturer Phone7634458639
Manufacturer G1C.R. BARD, INC. (GFO)
Manufacturer Street289 BAY ROAD
Manufacturer CityQUEENSBURY NY 12804
Manufacturer CountryUS
Manufacturer Postal Code12804
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameLUTONIX 035AV DRUG COATED BALLOON PTA CATHETER
Generic NameDRUG COATED BALLOON PTA CATHETER
Product CodePRC
Date Received2018-12-12
Returned To Mfg2018-12-11
Model Number9010
Catalog NumberLX35100860V
Lot NumberGFCQ2569
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerC.R. BARD, INC. (GFO)
Manufacturer Address289 BAY ROAD QUEENSBURY NY 12804 US 12804


Patients

Patient NumberTreatmentOutcomeDate
10 2018-12-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.